Development of a model for nerve agent inhalation in conscious rats

References

• Abbas F. (1984). Report of the specialists appointed by the Secretary-General of the United Nations to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. Arch Belg Suppl:302–10
   PubMedGoogle Scholar
• Alexander DJ, Collins CJ, Coombs DW, et al. (2008). Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol 20:1179–89
   PubMed Web of Science ®Google Scholar
• Anthony JS, Haley M, Manthei J, et al. (2004). Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB). Inhal Toxicol 16:103–11
   PubMed Web of Science ®Google Scholar
• Anzueto A, Berdine GG, Moore GT, et al. (1986). Pathophysiology of soman intoxication in primates. Toxicol Appl Pharmacol 86:56–68
   PubMed Web of Science ®Google Scholar
• Atchison CR, Sheridan RE, Duniho SM, Shih TM. (2004). Development of a Guinea pig model for low-dose, long-term exposure to organophosphorus nerve agents. Toxicol Mech Meth 14:183–94
   PubMed Web of Science ®Google Scholar
• Bajgar J. (2004). Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216
   PubMed Web of Science ®Google Scholar
• Benton BJ, McGuire JM, Sommerville DR, et al. (2006). Effects of whole-body VX vapor exposure on lethality in rats. Inhal Toxicol 18:1091–9
   PubMed Web of Science ®Google Scholar
• Bide RW, Armour SJ, Yee E. (2000). Allometric respiration/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans. J Appl Toxicol 20:273–90
   PubMed Web of Science ®Google Scholar
• Broughton E. (2005). The Bhopal disaster and its aftermath: a review. Environmental Health: A Global Access Science Source 4:6
   Google Scholar
• Dabisch PA, Davis EA, Renner JA, et al. (2008). Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition. Inhal Toxicol 20:149–56
   PubMed Web of Science ®Google Scholar
• Dunn MA, Sidell FR. (1989). Progress in medical defense against nerve agents. J Am Med Assoc 262:649–52
   PubMed Web of Science ®Google Scholar
• Eckerman I. (2005). The Bhopal gas leak: analyses of causes and consequences by three different models. J Loss Prevent Process Indust 18:213–17
   Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
   PubMed Web of Science ®Google Scholar
• Fawcett WP, Aracava Y, Adler M, et al. (2009). Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibition. J Pharmacol Exp Therapeut 328:516–24
   PubMed Web of Science ®Google Scholar
• Feakes D. (2003). Global civil society and chemical and biological warfare. In Kaldor M, Anheier H, Glasius M, eds. Global civil society yearbook 2003. London, UK: LSE Global Governance
   Google Scholar
• Flegal KM, Carroll MD, Ogden CL, Curtin LR. (2010). Prevalence and trends in obesity among us adults, 1999–2008. J Am Med Assoc 303:235–41
   PubMed Web of Science ®Google Scholar
• Franz DR, Hilaski R. (1990). Sequence of cardiorespiratory effects of soman altered by route of administration. Toxicology Lett 51:221–5
   PubMed Web of Science ®Google Scholar
• Gupta RC, Patterson GT, Dettbarn WD. (1985). Mechanisms involved in the development of tolerance to DFP toxicity. Fund Appl Toxicol 5:S17–28
   Google Scholar
• Guyton AC. (1947). Measurement of the respiratory volumes of laboratory animals. Am J Physiol 150:70–7
   PubMed Web of Science ®Google Scholar
• Haigh JR, Lefkowitz LJ, Capacio BR, et al. (2008). Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays. Chem Biol Interact 175:417–20
   PubMed Web of Science ®Google Scholar
• Kirby RD, ed. (2005). Potential military chemical/biological agents and compounds. Washington, D.C.: Dept. of the Army
   Google Scholar
• Maynard RL, Chilcott RP. (2009). Toxicology of chemical warfare agents. In Ballantyne B, Marrs TC, Syversen T, eds. General and applied toxicology. 3rd ed. Hoboken (NJ): John Wiley and Sons Limited
   Google Scholar
• Mioduszewski R, Manthei J, Way R, et al. (2002a). Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol Sci 66:176–84
   PubMed Web of Science ®Google Scholar
• Mioduszewski RJ, Manthei JH, Way RA, et al. (2002b). Low-level sarin vapor exposure in rats: effect of exposure concentration and duration on pupil size [online]. Ft. Belvoir: Defense Technical Information Center. Available from: http://handle.dtic.mil/100.2/ADA402869 [last accessed 13 May 2013]
   Google Scholar
• Muse WT, Thomson S, Crouse C, Matson K. (2006). Generation, sampling, and analysis for low-level GB (Sarin) and GF (Cyclosarin) vapor for inhalation toxicology studies. Inhal Toxicol 18:1101–8
   PubMed Web of Science ®Google Scholar
• Niven AS, Roop SA. (2004). Inhalational exposure to nerve agents. Respir Care Clin N Am 10:59–74
   PubMedGoogle Scholar
• Phalen RF. (1976). Inhalation exposure of animals. Environ Health Perspect 16:17–24
   PubMed Web of Science ®Google Scholar
• Redemann CE, Chaikin SW, Fearing RB, et al. (1948). The vapor pressures of forty-one fluorine-containing organic compounds. J Am Chem Soc 70:3604–6
   PubMed Web of Science ®Google Scholar
• Rickett DL, Glenn JF, Beers ET. (1986). Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicol 7:225–36
   PubMed Web of Science ®Google Scholar
• Shih ML, McMonagle JD, Dolzine TW, Gresham VC. (1994). Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents. J Appl Toxicol 14:195–9
   PubMed Web of Science ®Google Scholar
• Shih TM, Kan RK, McDonough JH. (2005). In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 157–8:293–303
   Google Scholar
• Sidell FR, Borak J. (1992). Chemical warfare agents: II. Nerve agents. Ann Em Med 21:865–71
   PubMed Web of Science ®Google Scholar
• Sidell FR, Takafuji ET, Franz DR. (1997). Medical aspects of chemical and biological warfare. Washington (DC), Falls Church (VA), Fort Sam Houston (TX), Fort Detrick, Frederick (MD), Bethesda (MD): Borden Institute, Office of the Surgeon General, United States Army Medical Department Center and School; United States Army Medical Research and Material Command; Uniformed Services University of the Health Sciences
   Google Scholar
• Smithson AE, Levy L-A, Henry L. Stimson Center. (2000). Ataxia: the chemical and biological terrorism threat and the US response. Washington, DC: Henry L. Stimson Center
   Google Scholar
• Terry AV Jr, Buccafusco JJ, Gearhart DA, et al. (2011). Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience 176:237–53
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. (2010). Age and sex composition: 2010 census briefs. Washington, D.C.: U.S. Government Printing Office
   Google Scholar
• Vijayaraghavan R, Schaper M, Thompson R, et al. (1993). Characteristic modifications of the breathing pattern of mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch Toxicol 67:478–90
   PubMed Web of Science ®Google Scholar
• Villa AF, Houze P, Monier C, et al. (2007). Toxic doses of paraoxon alter the respiratory pattern without causing respiratory failure in rats. Toxicology 232:37–49
   PubMed Web of Science ®Google Scholar
• Wecker L, Kiauta T, Dettbarn WD. (1978). Relationship between acetylcholinesterase inhibition and the development of a myopathy. J Pharmacol Exp Ther 206:97–104
   PubMed Web of Science ®Google Scholar